Members

Professor Jamie Hutchison has led multiple high-impact studies of brain injury and critical illness in children and adults. In these basic science, translational biology, and therapeutic studies, he and his teams have uncovered molecular and microvascular mechanisms and helped guide clinical management. His primary focus has been cerebral ischemia, cardiac arrest, traumatic brain injury (TBI), and lung injury, and his collaborative studies include status epilepticus, transfusion medicine and septic shock. The current goals of Dr. Hutchison’s research are to discover and establish clinical, biochemical tests for use in cardiac arrest and TBI and to prove the clinical utility of a neuroprotective drug in cardiac arrest.

He has been awarded 70 peer-reviewed grants, published over 120 peer-reviewed papers, and given multiple presentations and media interviews nationally and internationally. He is the past chair of the Canadian Critical Care Translational Biology Group, the current Co-chair, with Dr. Alexis Turgeon, of the Canadian Traumatic Brain Injury Research Consortium (CTRC), funded by the Canadian Institutes of Health Research (CIHR), and a member of the International Initiative for Traumatic Brain Injury Research. More than 20 graduate students and post-doctoral research fellows have been trained in the Hutchison laboratory, and multiple trainees and young clinician-scientist investigators have benefitted from his mentorship. Dr Hutchison received the 2023 Distinguished Lecturer Award in Critical Care Sciences from the CIHR Institute of Circulatory and Respiratory Health and the Canadian Critical Care Society. He is currently advocating to designate moderate to severe TBI as a chronic condition in Canada on behalf of patients and their families, the CTRC and Brain Injury Canada.